Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-019600

CHIEF OPERATING OFFICER sold 50,000 shares at an average $25.06 ($1,252,826)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-07-12 Sale : show line 1 in the form 10b5-1 −17,475 $25.07 $438,095 376,552 I
2024-07-15 Sale : show line 2 in the form 10b5-1 −30,978 $25.05 $776,039 345,574 I
2024-07-16 Sale : show line 3 in the form 10b5-1 −1,547 $25.01 $38,692 344,027 I
Open-market sales · 50,000 sh · avg $25.06 · $1,252,826
Loading xslF345X05/form4-07162024_090759.xml…